Ledger.Open graph →
SEC Form D · filed January 19, 2024

Clarametyx Biosciences, Inc

Offering
$33.1M
Sold
$27.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
COLUMBUS, OH
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

William G. Baumel · Columbus, OHDirectorMichael G. Layman · Hopewell, OHDirectorLarry G. Edwards · Columbus, OHDirectorMichael Triplett Ii · Columbus, OHDirectorLarry G. Edwards · Columbus, OHDirectorPeter G. Kleinhenz · Columbus, OHDirectorMichael Triplett Ii · Columbus, OHDirectorJ. V. Cain · Sag Harbor, NYDirectorPeter G. Kleinhenz · Columbus, OHDirectorMichael G. Layman · Hopewell, OHDirectorChuck G. Bramlage · Columbus, OHDirectorDavid Richards · New York, NYExecWilliam G. Baumel · Columbus, OHDirectorWayne D. Embree · Columbus, OHDirectorDavid Richards · New York, NYExecChuck G. Bramlage · Columbus, OHDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗